Mr. Speaker, as I just mentioned, we are engaged with suppliers on this issue, and many of the suppliers we spoke with said that the science is not there yet in terms of their production of boosters. We are, therefore, engaged with them to ensure that Canada is prioritized when that science is ready and when they are offering boosters in terms of contractual negotiations. As usual, we are placing Canadian interests at the very forefront of vaccine production.
Did I mention that we have had 600,000-plus vaccines delivered into this country to date this week? Our largest shipment—